Macrophage activation syndrome as an early presentation of Lupus.
Liza J
LJ
McCann
Nathan
N
Hasson
Clarissa A
CA
Pilkington
D002648:Child; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D042241:Early Diagnosis; D005260:Female; D005334:Fever / Q000209:etiology / Q000503:physiopathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000276:immunology* / Q000473:pathology* / Q000628:therapy; D008231:Lymphopenia / Q000209:etiology / Q000503:physiopathology; D008262:Macrophage Activation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D010951:Plasma Exchange; D013577:Syndrome; D016896:Treatment Outcome
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone